ERBB2 and Alzheimer disease: As oncogenic receptor tyrosine kinase, ERBB2 was identified to have a critical function in its monomeric form and increased levels of ERBB2 in the hippocampus was suggested as a potential diagnostic marker of sporadic AD [34].